Last updated: 2026-09-05 17:17:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Opko Health Inc. (OPK) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.65, with a market capitalisation of $1.26B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.98 to $1.73. This page covers its latest market performance, valuation, price trends and company information.
$1.26B | |
$1.59 | |
$19.20 | |
$0.55 | |
$1.61 | |
2.10M | |
-- | |
-- | |
$1.73 | |
$0.98 | |
-- | |
-- |
Opko Health Inc. (OPK) last closed at $1.61 as of 2026-09-04 23:57:00, unchanged from the previous close of $1.61.
During the latest regular trading session, OPK traded between $0.55 and $19.20, with a volume of 2.10M shares. The closing price was near the lower end and near the upper end of its 52-week range.
Over the past seven days, Opko Health Inc. (OPK) moved from $1.48 to $1.65, representing a gain of 11.15% ($0.17).
The stock traded between $1.58 and $1.67 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 3.94 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 88.7%
OPK is currently trading at $1.65, placing it 88.7% of the way from its 52-week low of $0.98 to its 52-week high of $1.73. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 2275 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Opko Health Inc. (OPK) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.